Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Learn how to identify crypto coins to hold long term based on fundamentals, use cases, and risk tolerance. Build a resilient, diversified portfolio with smart criteria.
28,040 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
The U.S. public debt is approaching $50 trillion, pushing lawmakers and investors to re-evaluate fiscal promises and ...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...
Nebius surges on a pair of cloud deals and a swelling backlog, but a late Q4 miss and execution doubts keep investors...
Cursor, valued near $29 billion, stands at the center of a fast-moving AI coding boom. The company faces intense grow...
Oil prices push higher as supply fears mount, triggering a broad debt selloff and jittery stock futures. Iran tension...
AMD's growth story is gaining steam as data centers, AI workloads, and CPU/GPU innovations align. This guide breaks d...
Credit models are evolving as BNPL usage, rent payment history, and trended data tighten the grip on underwriting. Th...
Federal agencies are deploying Anthropic’s Mythos to hunt bugs in critical code, a move that broadens AI’s role in na...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
The stock market live february narrative took a turn as Nvidia’s earnings digest kept major averages flat, with SPY h...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...